Recent Acquisitions
NuSil Technology, in its continuing dedication to providing industry-leading silicone materials, acquired the Pharmaceutical Antifoam (Simethicone) business from Bluestar Silicones. As part of the acquisition NuSil will gain seven key Simethicone products used in pharmaceutical applications.
Simethicones are wide spectrum antifoam and defoaming products which have been used successfully in various industries including pharmaceutical, food and cosmetics. In the pharmaceutical industry, Simethicones have shown efficacy as antifoams in processes such as biological fermentations and in the manufacture of antibiotics. Simethicones are also widely used as active pharmaceutical ingredients in anti-flatulent formulations.
This acquisition,
when combined with the ingestible Simethicone acquired from GE Advanced Materials in 2004,
positions NuSil to provide all of the most innovative healthcare application
materials to its new and existing customers. Fortune 500 device manufacturers choose NuSil because
of its custom approach to materials development and unprecedented commitment to customer service.